Synopsis Bare-Metal Stents (BMSs) and Drug-Eluting Stents (DESs) both types induce platelet adhesion and activation, leading to stent thrombosis, which requires Dual Anti-platelet therapy (DAPT). Recent studies have shown that newer DESs are more effective than BMSs in reducing stent thrombosis. This week’s “ MED FACT ” discusses a clinical trial from JAMA Cardiology, “ Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy A Meta-analysis ” Oct 2018. Authors: Shah et al.
Key Takeaways DESs optimized for biocompatibility are safer and more effective than BMSs even with a single month of DAPT after implantation. Objective: To evaluate the efficacy and safety of DESs compared with BMSs for coronary intervention with a single month of DAPT. Study Type: Meta-Analysis Participants: 3943 What Was The…
